FDA Drug Application (021007) for AGENERASE by GLAXOSMITHKLINE

Back to FDA Applications sponsored by GLAXOSMITHKLINE

Application Number021007
Product Number001
FormCAPSULE;ORAL
Dosage50MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameAGENERASE
Active IngredientAMPRENAVIR



Back to FDA Applications sponsored by GLAXOSMITHKLINE